DEFINITIVE PROXY STATEMENT

Company

Cardiff Oncology, Inc.

Filed

May 29, 2013

Period of Report

July 18, 2013

Accession Number

0001104659-13-045330

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →